Eye injection shows promise for diabetic retinopathy blood flow
NCT ID NCT03006081
First seen Jan 04, 2026 · Last updated May 20, 2026 · Updated 22 times
Summary
This study tested whether aflibercept, a medication injected into the eye, can improve areas of poor blood flow in the retina of people with diabetic retinopathy. The trial involved 38 adults with nonproliferative diabetic retinopathy and moderate retinal nonperfusion. The main goal was to measure changes in the size of the nonperfused area over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Asan medical center
Seoul, Seoul, 05505, South Korea
Conditions
Explore the condition pages connected to this study.